Plain-English translation of NCT07260253 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether transcranial direct current stimulation (tDCS)—a type of gentle brain stimulation you do at home—combined with speech therapy delivered by video can help people with logopenic variant primary progressive aphasia improve their communication skills. This condition causes gradual difficulty with language and is often related to Alzheimer's disease. Researchers want to see if adding this brain stimulation to speech therapy works better than speech therapy alone.
Logopenic variant primary progressive aphasia causes people to slowly lose their ability to speak and understand language, and there are limited treatment options available. This trial exists to see if combining brain stimulation with speech therapy might offer a new way to help people keep their communication abilities longer.
You likely qualify if…
You likely don't qualify if…
You would attend an initial visit at the research site for brain imaging and testing, then participate in virtual speech therapy sessions from home over several weeks. During these sessions, you would also use a small brain stimulation device at home that is remotely supervised by the research team. You would complete language and thinking tests before and after treatment to measure any changes in your communication abilities. Your study partner would attend training before treatment begins and participate in some teleconference meetings as needed.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States